Bromfenac
| |
| Bromfenac
| |
| Systematic (IUPAC) name | |
| 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C15H12NO2 |
| Mol. mass | 383.17 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | Oral (discontinued) ophthalmic |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Bromfenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription capsule (discontinued; brand name Duract) or as an ophthalmic solution (brand name Xibrom).
External links
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
